nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—ABCB1—kidney cancer	0.248	1	CbGaD
Reboxetine—ABCB1—Temsirolimus—kidney cancer	0.0494	0.0912	CbGbCtD
Reboxetine—HTR2C—Sorafenib—kidney cancer	0.0473	0.0874	CbGbCtD
Reboxetine—CYP2D6—Temsirolimus—kidney cancer	0.0465	0.086	CbGbCtD
Reboxetine—CYP3A4—Everolimus—kidney cancer	0.0438	0.0809	CbGbCtD
Reboxetine—CYP3A4—Temsirolimus—kidney cancer	0.0296	0.0547	CbGbCtD
Reboxetine—ABCB1—Pazopanib—kidney cancer	0.0259	0.0479	CbGbCtD
Reboxetine—CYP2D6—Pazopanib—kidney cancer	0.0244	0.0452	CbGbCtD
Reboxetine—ABCB1—Dactinomycin—kidney cancer	0.0237	0.0438	CbGbCtD
Reboxetine—ABCB1—Gemcitabine—kidney cancer	0.0187	0.0347	CbGbCtD
Reboxetine—ABCB1—Erlotinib—kidney cancer	0.0185	0.0342	CbGbCtD
Reboxetine—CYP2D6—Erlotinib—kidney cancer	0.0174	0.0322	CbGbCtD
Reboxetine—ABCB1—Paclitaxel—kidney cancer	0.0169	0.0313	CbGbCtD
Reboxetine—CYP3A4—Pazopanib—kidney cancer	0.0155	0.0287	CbGbCtD
Reboxetine—ABCB1—Sorafenib—kidney cancer	0.015	0.0278	CbGbCtD
Reboxetine—ABCB1—Vinblastine—kidney cancer	0.0149	0.0275	CbGbCtD
Reboxetine—ABCB1—Vincristine—kidney cancer	0.0146	0.027	CbGbCtD
Reboxetine—CYP2D6—Sorafenib—kidney cancer	0.0142	0.0262	CbGbCtD
Reboxetine—CYP2D6—Vinblastine—kidney cancer	0.014	0.0259	CbGbCtD
Reboxetine—ABCB1—Sunitinib—kidney cancer	0.0122	0.0225	CbGbCtD
Reboxetine—CYP3A4—Erlotinib—kidney cancer	0.0111	0.0205	CbGbCtD
Reboxetine—CYP3A4—Paclitaxel—kidney cancer	0.0101	0.0188	CbGbCtD
Reboxetine—ABCB1—Doxorubicin—kidney cancer	0.00913	0.0169	CbGbCtD
Reboxetine—CYP3A4—Sorafenib—kidney cancer	0.00901	0.0167	CbGbCtD
Reboxetine—CYP3A4—Vinblastine—kidney cancer	0.0089	0.0165	CbGbCtD
Reboxetine—CYP3A4—Vincristine—kidney cancer	0.00875	0.0162	CbGbCtD
Reboxetine—CYP2D6—Doxorubicin—kidney cancer	0.0086	0.0159	CbGbCtD
Reboxetine—CYP3A4—Sunitinib—kidney cancer	0.0073	0.0135	CbGbCtD
Reboxetine—CYP3A4—Doxorubicin—kidney cancer	0.00547	0.0101	CbGbCtD
Reboxetine—Body temperature increased—Dactinomycin—kidney cancer	0.000137	0.000649	CcSEcCtD
Reboxetine—Abdominal pain—Dactinomycin—kidney cancer	0.000137	0.000649	CcSEcCtD
Reboxetine—Visual impairment—Capecitabine—kidney cancer	0.000137	0.000648	CcSEcCtD
Reboxetine—Asthenia—Sorafenib—kidney cancer	0.000136	0.000646	CcSEcCtD
Reboxetine—Malaise—Paclitaxel—kidney cancer	0.000136	0.000644	CcSEcCtD
Reboxetine—Vertigo—Paclitaxel—kidney cancer	0.000135	0.000641	CcSEcCtD
Reboxetine—Syncope—Paclitaxel—kidney cancer	0.000135	0.00064	CcSEcCtD
Reboxetine—Leukopenia—Paclitaxel—kidney cancer	0.000135	0.000639	CcSEcCtD
Reboxetine—Hypersensitivity—Sunitinib—kidney cancer	0.000135	0.000639	CcSEcCtD
Reboxetine—Decreased appetite—Vincristine—kidney cancer	0.000134	0.000637	CcSEcCtD
Reboxetine—Vomiting—Erlotinib—kidney cancer	0.000134	0.000637	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Vincristine—kidney cancer	0.000133	0.000633	CcSEcCtD
Reboxetine—Rash—Erlotinib—kidney cancer	0.000133	0.000631	CcSEcCtD
Reboxetine—Dermatitis—Erlotinib—kidney cancer	0.000133	0.000631	CcSEcCtD
Reboxetine—Palpitations—Paclitaxel—kidney cancer	0.000133	0.000631	CcSEcCtD
Reboxetine—Hyponatraemia—Doxorubicin—kidney cancer	0.000133	0.000629	CcSEcCtD
Reboxetine—Insomnia—Gemcitabine—kidney cancer	0.000133	0.000629	CcSEcCtD
Reboxetine—Eye disorder—Capecitabine—kidney cancer	0.000133	0.000629	CcSEcCtD
Reboxetine—Headache—Erlotinib—kidney cancer	0.000132	0.000627	CcSEcCtD
Reboxetine—Tinnitus—Capecitabine—kidney cancer	0.000132	0.000627	CcSEcCtD
Reboxetine—Loss of consciousness—Paclitaxel—kidney cancer	0.000132	0.000627	CcSEcCtD
Reboxetine—Constipation—Vincristine—kidney cancer	0.000132	0.000627	CcSEcCtD
Reboxetine—Diplopia—Doxorubicin—kidney cancer	0.000132	0.000627	CcSEcCtD
Reboxetine—Paraesthesia—Gemcitabine—kidney cancer	0.000132	0.000625	CcSEcCtD
Reboxetine—Cardiac disorder—Capecitabine—kidney cancer	0.000132	0.000624	CcSEcCtD
Reboxetine—Asthenia—Sunitinib—kidney cancer	0.000131	0.000622	CcSEcCtD
Reboxetine—Dyspnoea—Gemcitabine—kidney cancer	0.000131	0.00062	CcSEcCtD
Reboxetine—Nausea—Vinblastine—kidney cancer	0.00013	0.000619	CcSEcCtD
Reboxetine—Somnolence—Gemcitabine—kidney cancer	0.00013	0.000618	CcSEcCtD
Reboxetine—Nausea—Everolimus—kidney cancer	0.00013	0.000617	CcSEcCtD
Reboxetine—Diarrhoea—Sorafenib—kidney cancer	0.00013	0.000616	CcSEcCtD
Reboxetine—Hypertension—Paclitaxel—kidney cancer	0.00013	0.000616	CcSEcCtD
Reboxetine—Angiopathy—Capecitabine—kidney cancer	0.000129	0.00061	CcSEcCtD
Reboxetine—Immune system disorder—Capecitabine—kidney cancer	0.000128	0.000608	CcSEcCtD
Reboxetine—Chest pain—Paclitaxel—kidney cancer	0.000128	0.000608	CcSEcCtD
Reboxetine—Mediastinal disorder—Capecitabine—kidney cancer	0.000128	0.000606	CcSEcCtD
Reboxetine—Anxiety—Paclitaxel—kidney cancer	0.000128	0.000605	CcSEcCtD
Reboxetine—Face oedema—Doxorubicin—kidney cancer	0.000128	0.000605	CcSEcCtD
Reboxetine—Decreased appetite—Gemcitabine—kidney cancer	0.000127	0.000605	CcSEcCtD
Reboxetine—Hypersensitivity—Dactinomycin—kidney cancer	0.000127	0.000605	CcSEcCtD
Reboxetine—Chills—Capecitabine—kidney cancer	0.000127	0.000604	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000127	0.000603	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000127	0.000601	CcSEcCtD
Reboxetine—Discomfort—Paclitaxel—kidney cancer	0.000127	0.0006	CcSEcCtD
Reboxetine—Gastrointestinal pain—Vincristine—kidney cancer	0.000126	0.0006	CcSEcCtD
Reboxetine—Dizziness—Sorafenib—kidney cancer	0.000126	0.000596	CcSEcCtD
Reboxetine—Constipation—Gemcitabine—kidney cancer	0.000125	0.000595	CcSEcCtD
Reboxetine—Nausea—Erlotinib—kidney cancer	0.000125	0.000595	CcSEcCtD
Reboxetine—Dry mouth—Paclitaxel—kidney cancer	0.000125	0.000594	CcSEcCtD
Reboxetine—Diarrhoea—Sunitinib—kidney cancer	0.000125	0.000593	CcSEcCtD
Reboxetine—Mental disorder—Capecitabine—kidney cancer	0.000124	0.000589	CcSEcCtD
Reboxetine—Asthenia—Dactinomycin—kidney cancer	0.000124	0.000589	CcSEcCtD
Reboxetine—Confusional state—Paclitaxel—kidney cancer	0.000124	0.000587	CcSEcCtD
Reboxetine—Blood creatinine increased—Doxorubicin—kidney cancer	0.000124	0.000587	CcSEcCtD
Reboxetine—Malnutrition—Capecitabine—kidney cancer	0.000123	0.000586	CcSEcCtD
Reboxetine—Dehydration—Doxorubicin—kidney cancer	0.000123	0.000583	CcSEcCtD
Reboxetine—Abdominal pain—Vincristine—kidney cancer	0.000122	0.00058	CcSEcCtD
Reboxetine—Body temperature increased—Vincristine—kidney cancer	0.000122	0.00058	CcSEcCtD
Reboxetine—Liver function test abnormal—Doxorubicin—kidney cancer	0.000122	0.000579	CcSEcCtD
Reboxetine—Infection—Paclitaxel—kidney cancer	0.000122	0.000579	CcSEcCtD
Reboxetine—Dysgeusia—Capecitabine—kidney cancer	0.000121	0.000573	CcSEcCtD
Reboxetine—Dizziness—Sunitinib—kidney cancer	0.000121	0.000573	CcSEcCtD
Reboxetine—Feeling abnormal—Gemcitabine—kidney cancer	0.000121	0.000573	CcSEcCtD
Reboxetine—Shock—Paclitaxel—kidney cancer	0.000121	0.000573	CcSEcCtD
Reboxetine—Vomiting—Sorafenib—kidney cancer	0.000121	0.000573	CcSEcCtD
Reboxetine—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000121	0.000573	CcSEcCtD
Reboxetine—Nervous system disorder—Paclitaxel—kidney cancer	0.00012	0.000571	CcSEcCtD
Reboxetine—Tachycardia—Paclitaxel—kidney cancer	0.00012	0.000568	CcSEcCtD
Reboxetine—Rash—Sorafenib—kidney cancer	0.00012	0.000568	CcSEcCtD
Reboxetine—Dermatitis—Sorafenib—kidney cancer	0.00012	0.000568	CcSEcCtD
Reboxetine—Breast disorder—Doxorubicin—kidney cancer	0.000119	0.000566	CcSEcCtD
Reboxetine—Skin disorder—Paclitaxel—kidney cancer	0.000119	0.000566	CcSEcCtD
Reboxetine—Headache—Sorafenib—kidney cancer	0.000119	0.000564	CcSEcCtD
Reboxetine—Hyperhidrosis—Paclitaxel—kidney cancer	0.000119	0.000563	CcSEcCtD
Reboxetine—Diarrhoea—Dactinomycin—kidney cancer	0.000118	0.000562	CcSEcCtD
Reboxetine—Anorexia—Paclitaxel—kidney cancer	0.000117	0.000555	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000117	0.000553	CcSEcCtD
Reboxetine—Muscular weakness—Doxorubicin—kidney cancer	0.000117	0.000553	CcSEcCtD
Reboxetine—Vomiting—Sunitinib—kidney cancer	0.000116	0.000551	CcSEcCtD
Reboxetine—Body temperature increased—Gemcitabine—kidney cancer	0.000116	0.00055	CcSEcCtD
Reboxetine—Tremor—Capecitabine—kidney cancer	0.000116	0.000549	CcSEcCtD
Reboxetine—Rash—Sunitinib—kidney cancer	0.000115	0.000547	CcSEcCtD
Reboxetine—Dermatitis—Sunitinib—kidney cancer	0.000115	0.000546	CcSEcCtD
Reboxetine—Hypotension—Paclitaxel—kidney cancer	0.000115	0.000544	CcSEcCtD
Reboxetine—Ill-defined disorder—Capecitabine—kidney cancer	0.000115	0.000543	CcSEcCtD
Reboxetine—Headache—Sunitinib—kidney cancer	0.000114	0.000543	CcSEcCtD
Reboxetine—Influenza—Doxorubicin—kidney cancer	0.000114	0.000542	CcSEcCtD
Reboxetine—Anaemia—Capecitabine—kidney cancer	0.000114	0.000541	CcSEcCtD
Reboxetine—Hypersensitivity—Vincristine—kidney cancer	0.000114	0.00054	CcSEcCtD
Reboxetine—Nausea—Sorafenib—kidney cancer	0.000113	0.000535	CcSEcCtD
Reboxetine—Malaise—Capecitabine—kidney cancer	0.000111	0.000528	CcSEcCtD
Reboxetine—Insomnia—Paclitaxel—kidney cancer	0.000111	0.000527	CcSEcCtD
Reboxetine—Vertigo—Capecitabine—kidney cancer	0.000111	0.000526	CcSEcCtD
Reboxetine—Asthenia—Vincristine—kidney cancer	0.000111	0.000526	CcSEcCtD
Reboxetine—Syncope—Capecitabine—kidney cancer	0.000111	0.000525	CcSEcCtD
Reboxetine—Leukopenia—Capecitabine—kidney cancer	0.00011	0.000524	CcSEcCtD
Reboxetine—Paraesthesia—Paclitaxel—kidney cancer	0.00011	0.000523	CcSEcCtD
Reboxetine—Vomiting—Dactinomycin—kidney cancer	0.00011	0.000522	CcSEcCtD
Reboxetine—Bronchitis—Doxorubicin—kidney cancer	0.00011	0.000521	CcSEcCtD
Reboxetine—Dyspnoea—Paclitaxel—kidney cancer	0.000109	0.000519	CcSEcCtD
Reboxetine—Somnolence—Paclitaxel—kidney cancer	0.000109	0.000518	CcSEcCtD
Reboxetine—Palpitations—Capecitabine—kidney cancer	0.000109	0.000518	CcSEcCtD
Reboxetine—Rash—Dactinomycin—kidney cancer	0.000109	0.000517	CcSEcCtD
Reboxetine—Nausea—Sunitinib—kidney cancer	0.000109	0.000515	CcSEcCtD
Reboxetine—Loss of consciousness—Capecitabine—kidney cancer	0.000108	0.000515	CcSEcCtD
Reboxetine—Dyspepsia—Paclitaxel—kidney cancer	0.000108	0.000513	CcSEcCtD
Reboxetine—Dysuria—Doxorubicin—kidney cancer	0.000107	0.000507	CcSEcCtD
Reboxetine—Decreased appetite—Paclitaxel—kidney cancer	0.000107	0.000506	CcSEcCtD
Reboxetine—Hypertension—Capecitabine—kidney cancer	0.000107	0.000506	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000106	0.000503	CcSEcCtD
Reboxetine—Diarrhoea—Vincristine—kidney cancer	0.000106	0.000502	CcSEcCtD
Reboxetine—Pollakiuria—Doxorubicin—kidney cancer	0.000105	0.0005	CcSEcCtD
Reboxetine—Asthenia—Gemcitabine—kidney cancer	0.000105	0.000499	CcSEcCtD
Reboxetine—Chest pain—Capecitabine—kidney cancer	0.000105	0.000499	CcSEcCtD
Reboxetine—Constipation—Paclitaxel—kidney cancer	0.000105	0.000498	CcSEcCtD
Reboxetine—Anxiety—Capecitabine—kidney cancer	0.000105	0.000497	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000104	0.000495	CcSEcCtD
Reboxetine—Discomfort—Capecitabine—kidney cancer	0.000104	0.000493	CcSEcCtD
Reboxetine—Weight decreased—Doxorubicin—kidney cancer	0.000103	0.00049	CcSEcCtD
Reboxetine—Hyperglycaemia—Doxorubicin—kidney cancer	0.000103	0.000489	CcSEcCtD
Reboxetine—Dry mouth—Capecitabine—kidney cancer	0.000103	0.000488	CcSEcCtD
Reboxetine—Nausea—Dactinomycin—kidney cancer	0.000103	0.000488	CcSEcCtD
Reboxetine—Dizziness—Vincristine—kidney cancer	0.000102	0.000485	CcSEcCtD
Reboxetine—Infestation NOS—Doxorubicin—kidney cancer	0.000102	0.000483	CcSEcCtD
Reboxetine—Infestation—Doxorubicin—kidney cancer	0.000102	0.000483	CcSEcCtD
Reboxetine—Confusional state—Capecitabine—kidney cancer	0.000102	0.000482	CcSEcCtD
Reboxetine—Feeling abnormal—Paclitaxel—kidney cancer	0.000101	0.00048	CcSEcCtD
Reboxetine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.0001	0.000476	CcSEcCtD
Reboxetine—Diarrhoea—Gemcitabine—kidney cancer	0.0001	0.000476	CcSEcCtD
Reboxetine—Infection—Capecitabine—kidney cancer	0.0001	0.000475	CcSEcCtD
Reboxetine—Shock—Capecitabine—kidney cancer	9.91e-05	0.00047	CcSEcCtD
Reboxetine—Urinary tract infection—Doxorubicin—kidney cancer	9.9e-05	0.00047	CcSEcCtD
Reboxetine—Conjunctivitis—Doxorubicin—kidney cancer	9.9e-05	0.00047	CcSEcCtD
Reboxetine—Nervous system disorder—Capecitabine—kidney cancer	9.88e-05	0.000469	CcSEcCtD
Reboxetine—Tachycardia—Capecitabine—kidney cancer	9.83e-05	0.000466	CcSEcCtD
Reboxetine—Vomiting—Vincristine—kidney cancer	9.83e-05	0.000466	CcSEcCtD
Reboxetine—Skin disorder—Capecitabine—kidney cancer	9.79e-05	0.000464	CcSEcCtD
Reboxetine—Sweating—Doxorubicin—kidney cancer	9.76e-05	0.000463	CcSEcCtD
Reboxetine—Urticaria—Paclitaxel—kidney cancer	9.75e-05	0.000463	CcSEcCtD
Reboxetine—Rash—Vincristine—kidney cancer	9.75e-05	0.000462	CcSEcCtD
Reboxetine—Hyperhidrosis—Capecitabine—kidney cancer	9.74e-05	0.000462	CcSEcCtD
Reboxetine—Dermatitis—Vincristine—kidney cancer	9.74e-05	0.000462	CcSEcCtD
Reboxetine—Body temperature increased—Paclitaxel—kidney cancer	9.7e-05	0.00046	CcSEcCtD
Reboxetine—Abdominal pain—Paclitaxel—kidney cancer	9.7e-05	0.00046	CcSEcCtD
Reboxetine—Headache—Vincristine—kidney cancer	9.68e-05	0.000459	CcSEcCtD
Reboxetine—Epistaxis—Doxorubicin—kidney cancer	9.6e-05	0.000456	CcSEcCtD
Reboxetine—Anorexia—Capecitabine—kidney cancer	9.6e-05	0.000456	CcSEcCtD
Reboxetine—Sinusitis—Doxorubicin—kidney cancer	9.55e-05	0.000453	CcSEcCtD
Reboxetine—Hypotension—Capecitabine—kidney cancer	9.41e-05	0.000447	CcSEcCtD
Reboxetine—Vomiting—Gemcitabine—kidney cancer	9.32e-05	0.000442	CcSEcCtD
Reboxetine—Bradycardia—Doxorubicin—kidney cancer	9.31e-05	0.000441	CcSEcCtD
Reboxetine—Rash—Gemcitabine—kidney cancer	9.25e-05	0.000439	CcSEcCtD
Reboxetine—Dermatitis—Gemcitabine—kidney cancer	9.24e-05	0.000438	CcSEcCtD
Reboxetine—Headache—Gemcitabine—kidney cancer	9.19e-05	0.000436	CcSEcCtD
Reboxetine—Nausea—Vincristine—kidney cancer	9.18e-05	0.000436	CcSEcCtD
Reboxetine—Rhinitis—Doxorubicin—kidney cancer	9.16e-05	0.000435	CcSEcCtD
Reboxetine—Insomnia—Capecitabine—kidney cancer	9.11e-05	0.000432	CcSEcCtD
Reboxetine—Pharyngitis—Doxorubicin—kidney cancer	9.07e-05	0.00043	CcSEcCtD
Reboxetine—Paraesthesia—Capecitabine—kidney cancer	9.05e-05	0.000429	CcSEcCtD
Reboxetine—Hypersensitivity—Paclitaxel—kidney cancer	9.04e-05	0.000429	CcSEcCtD
Reboxetine—Urinary tract disorder—Doxorubicin—kidney cancer	9.03e-05	0.000428	CcSEcCtD
Reboxetine—Connective tissue disorder—Doxorubicin—kidney cancer	8.98e-05	0.000426	CcSEcCtD
Reboxetine—Dyspnoea—Capecitabine—kidney cancer	8.98e-05	0.000426	CcSEcCtD
Reboxetine—Urethral disorder—Doxorubicin—kidney cancer	8.96e-05	0.000425	CcSEcCtD
Reboxetine—Dyspepsia—Capecitabine—kidney cancer	8.87e-05	0.000421	CcSEcCtD
Reboxetine—Visual impairment—Doxorubicin—kidney cancer	8.81e-05	0.000418	CcSEcCtD
Reboxetine—Asthenia—Paclitaxel—kidney cancer	8.81e-05	0.000418	CcSEcCtD
Reboxetine—Decreased appetite—Capecitabine—kidney cancer	8.76e-05	0.000415	CcSEcCtD
Reboxetine—Nausea—Gemcitabine—kidney cancer	8.71e-05	0.000413	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Capecitabine—kidney cancer	8.7e-05	0.000413	CcSEcCtD
Reboxetine—Constipation—Capecitabine—kidney cancer	8.62e-05	0.000409	CcSEcCtD
Reboxetine—Eye disorder—Doxorubicin—kidney cancer	8.54e-05	0.000405	CcSEcCtD
Reboxetine—Tinnitus—Doxorubicin—kidney cancer	8.52e-05	0.000404	CcSEcCtD
Reboxetine—Cardiac disorder—Doxorubicin—kidney cancer	8.48e-05	0.000402	CcSEcCtD
Reboxetine—Diarrhoea—Paclitaxel—kidney cancer	8.4e-05	0.000398	CcSEcCtD
Reboxetine—Feeling abnormal—Capecitabine—kidney cancer	8.3e-05	0.000394	CcSEcCtD
Reboxetine—Angiopathy—Doxorubicin—kidney cancer	8.29e-05	0.000393	CcSEcCtD
Reboxetine—Immune system disorder—Doxorubicin—kidney cancer	8.26e-05	0.000392	CcSEcCtD
Reboxetine—Gastrointestinal pain—Capecitabine—kidney cancer	8.24e-05	0.000391	CcSEcCtD
Reboxetine—Mediastinal disorder—Doxorubicin—kidney cancer	8.24e-05	0.000391	CcSEcCtD
Reboxetine—Chills—Doxorubicin—kidney cancer	8.2e-05	0.000389	CcSEcCtD
Reboxetine—Dizziness—Paclitaxel—kidney cancer	8.12e-05	0.000385	CcSEcCtD
Reboxetine—Mental disorder—Doxorubicin—kidney cancer	8.01e-05	0.00038	CcSEcCtD
Reboxetine—Urticaria—Capecitabine—kidney cancer	8e-05	0.00038	CcSEcCtD
Reboxetine—Abdominal pain—Capecitabine—kidney cancer	7.96e-05	0.000378	CcSEcCtD
Reboxetine—Body temperature increased—Capecitabine—kidney cancer	7.96e-05	0.000378	CcSEcCtD
Reboxetine—Malnutrition—Doxorubicin—kidney cancer	7.96e-05	0.000378	CcSEcCtD
Reboxetine—Tension—Doxorubicin—kidney cancer	7.81e-05	0.00037	CcSEcCtD
Reboxetine—Vomiting—Paclitaxel—kidney cancer	7.81e-05	0.00037	CcSEcCtD
Reboxetine—Dysgeusia—Doxorubicin—kidney cancer	7.79e-05	0.00037	CcSEcCtD
Reboxetine—Rash—Paclitaxel—kidney cancer	7.74e-05	0.000367	CcSEcCtD
Reboxetine—Dermatitis—Paclitaxel—kidney cancer	7.73e-05	0.000367	CcSEcCtD
Reboxetine—Nervousness—Doxorubicin—kidney cancer	7.73e-05	0.000367	CcSEcCtD
Reboxetine—Headache—Paclitaxel—kidney cancer	7.69e-05	0.000365	CcSEcCtD
Reboxetine—Hypersensitivity—Capecitabine—kidney cancer	7.42e-05	0.000352	CcSEcCtD
Reboxetine—Ill-defined disorder—Doxorubicin—kidney cancer	7.38e-05	0.00035	CcSEcCtD
Reboxetine—Anaemia—Doxorubicin—kidney cancer	7.35e-05	0.000349	CcSEcCtD
Reboxetine—Agitation—Doxorubicin—kidney cancer	7.31e-05	0.000347	CcSEcCtD
Reboxetine—Nausea—Paclitaxel—kidney cancer	7.29e-05	0.000346	CcSEcCtD
Reboxetine—Asthenia—Capecitabine—kidney cancer	7.23e-05	0.000343	CcSEcCtD
Reboxetine—Malaise—Doxorubicin—kidney cancer	7.18e-05	0.00034	CcSEcCtD
Reboxetine—Vertigo—Doxorubicin—kidney cancer	7.15e-05	0.000339	CcSEcCtD
Reboxetine—Syncope—Doxorubicin—kidney cancer	7.14e-05	0.000339	CcSEcCtD
Reboxetine—Leukopenia—Doxorubicin—kidney cancer	7.12e-05	0.000338	CcSEcCtD
Reboxetine—Palpitations—Doxorubicin—kidney cancer	7.03e-05	0.000334	CcSEcCtD
Reboxetine—Loss of consciousness—Doxorubicin—kidney cancer	6.99e-05	0.000332	CcSEcCtD
Reboxetine—Diarrhoea—Capecitabine—kidney cancer	6.89e-05	0.000327	CcSEcCtD
Reboxetine—Hypertension—Doxorubicin—kidney cancer	6.87e-05	0.000326	CcSEcCtD
Reboxetine—Chest pain—Doxorubicin—kidney cancer	6.77e-05	0.000321	CcSEcCtD
Reboxetine—Anxiety—Doxorubicin—kidney cancer	6.75e-05	0.00032	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	6.73e-05	0.000319	CcSEcCtD
Reboxetine—Discomfort—Doxorubicin—kidney cancer	6.69e-05	0.000318	CcSEcCtD
Reboxetine—Dizziness—Capecitabine—kidney cancer	6.66e-05	0.000316	CcSEcCtD
Reboxetine—Dry mouth—Doxorubicin—kidney cancer	6.63e-05	0.000314	CcSEcCtD
Reboxetine—Confusional state—Doxorubicin—kidney cancer	6.55e-05	0.000311	CcSEcCtD
Reboxetine—Infection—Doxorubicin—kidney cancer	6.45e-05	0.000306	CcSEcCtD
Reboxetine—Vomiting—Capecitabine—kidney cancer	6.41e-05	0.000304	CcSEcCtD
Reboxetine—Shock—Doxorubicin—kidney cancer	6.39e-05	0.000303	CcSEcCtD
Reboxetine—Nervous system disorder—Doxorubicin—kidney cancer	6.37e-05	0.000302	CcSEcCtD
Reboxetine—Rash—Capecitabine—kidney cancer	6.35e-05	0.000301	CcSEcCtD
Reboxetine—Dermatitis—Capecitabine—kidney cancer	6.35e-05	0.000301	CcSEcCtD
Reboxetine—Tachycardia—Doxorubicin—kidney cancer	6.34e-05	0.000301	CcSEcCtD
Reboxetine—Headache—Capecitabine—kidney cancer	6.31e-05	0.000299	CcSEcCtD
Reboxetine—Skin disorder—Doxorubicin—kidney cancer	6.31e-05	0.000299	CcSEcCtD
Reboxetine—Hyperhidrosis—Doxorubicin—kidney cancer	6.28e-05	0.000298	CcSEcCtD
Reboxetine—Anorexia—Doxorubicin—kidney cancer	6.19e-05	0.000294	CcSEcCtD
Reboxetine—Hypotension—Doxorubicin—kidney cancer	6.07e-05	0.000288	CcSEcCtD
Reboxetine—Nausea—Capecitabine—kidney cancer	5.98e-05	0.000284	CcSEcCtD
Reboxetine—Insomnia—Doxorubicin—kidney cancer	5.87e-05	0.000279	CcSEcCtD
Reboxetine—Paraesthesia—Doxorubicin—kidney cancer	5.83e-05	0.000277	CcSEcCtD
Reboxetine—Dyspnoea—Doxorubicin—kidney cancer	5.79e-05	0.000275	CcSEcCtD
Reboxetine—Somnolence—Doxorubicin—kidney cancer	5.77e-05	0.000274	CcSEcCtD
Reboxetine—Dyspepsia—Doxorubicin—kidney cancer	5.72e-05	0.000271	CcSEcCtD
Reboxetine—Decreased appetite—Doxorubicin—kidney cancer	5.65e-05	0.000268	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Doxorubicin—kidney cancer	5.61e-05	0.000266	CcSEcCtD
Reboxetine—Constipation—Doxorubicin—kidney cancer	5.55e-05	0.000263	CcSEcCtD
Reboxetine—Feeling abnormal—Doxorubicin—kidney cancer	5.35e-05	0.000254	CcSEcCtD
Reboxetine—Gastrointestinal pain—Doxorubicin—kidney cancer	5.31e-05	0.000252	CcSEcCtD
Reboxetine—Urticaria—Doxorubicin—kidney cancer	5.16e-05	0.000245	CcSEcCtD
Reboxetine—Abdominal pain—Doxorubicin—kidney cancer	5.13e-05	0.000244	CcSEcCtD
Reboxetine—Body temperature increased—Doxorubicin—kidney cancer	5.13e-05	0.000244	CcSEcCtD
Reboxetine—Hypersensitivity—Doxorubicin—kidney cancer	4.78e-05	0.000227	CcSEcCtD
Reboxetine—Asthenia—Doxorubicin—kidney cancer	4.66e-05	0.000221	CcSEcCtD
Reboxetine—Diarrhoea—Doxorubicin—kidney cancer	4.44e-05	0.000211	CcSEcCtD
Reboxetine—Dizziness—Doxorubicin—kidney cancer	4.29e-05	0.000204	CcSEcCtD
Reboxetine—Vomiting—Doxorubicin—kidney cancer	4.13e-05	0.000196	CcSEcCtD
Reboxetine—Rash—Doxorubicin—kidney cancer	4.09e-05	0.000194	CcSEcCtD
Reboxetine—Dermatitis—Doxorubicin—kidney cancer	4.09e-05	0.000194	CcSEcCtD
Reboxetine—Headache—Doxorubicin—kidney cancer	4.07e-05	0.000193	CcSEcCtD
Reboxetine—Nausea—Doxorubicin—kidney cancer	3.86e-05	0.000183	CcSEcCtD
